Conduit Financial Statements From 2010 to 2025

CDTTW Stock   0.01  0.0002  1.57%   
Conduit Pharmaceuticals financial statements provide useful quarterly and yearly information to potential Conduit Pharmaceuticals investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Conduit Pharmaceuticals financial statements helps investors assess Conduit Pharmaceuticals' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Conduit Pharmaceuticals' valuation are summarized below:
There are over eighty-seven available fundamental signals for Conduit Pharmaceuticals, which can be analyzed over time and compared to other ratios. All traders should should validate Conduit Pharmaceuticals' prevailing fundamental trends against the trends from 2010 to 2025 to make sure the company is sustainable.
Check Conduit Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Conduit Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 143.6 K, Selling General Administrative of 4.1 M or Total Revenue of 2.6 B, as well as many indicators such as Price To Sales Ratio of 0.088, Dividend Yield of 0.0235 or PTB Ratio of 0.23. Conduit financial statements analysis is a perfect complement when working with Conduit Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Conduit Pharmaceuticals Correlation against competitors.
For more information on how to buy Conduit Stock please use our How to Invest in Conduit Pharmaceuticals guide.

Conduit Pharmaceuticals Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.4 B3.3 B418.9 M
Slightly volatile
Short and Long Term Debt Total1.3 B1.2 B158.4 M
Slightly volatile
Other Current Liabilities322.3 M307 M41.3 M
Slightly volatile
Total Current Liabilities653.8 M622.7 M81.8 M
Slightly volatile
Cash388.8 M370.3 M47.8 M
Slightly volatile
Non Current Assets Total2.2 B2.1 B265.2 M
Slightly volatile
Long Term Debt1.5 M2.3 M1.1 M
Slightly volatile
Cash And Short Term Investments388.8 M370.3 M47.8 M
Slightly volatile
Common Stock Shares Outstanding25.4 M41.3 M13.3 M
Slightly volatile
Liabilities And Stockholders Equity3.4 B3.3 B418.9 M
Slightly volatile
Non Current Liabilities Total1.4 B1.3 B176.1 M
Slightly volatile
Other Current Assets76.8 M73.1 M9.5 M
Slightly volatile
Total Liabilities2.1 BB257.9 M
Slightly volatile
Total Current Assets1.3 B1.2 B153.7 M
Slightly volatile
Short Term Debt1.2 M1.1 M350.4 K
Slightly volatile
Common Stock477.9 K503 K8.6 M
Pretty Stable
Short and Long Term Debt638 K1.1 M314.4 K
Slightly volatile
Intangible Assets506 M481.9 M87.9 M
Slightly volatile
Property Plant And Equipment Net491.3 M552.8 M602.7 M
Slightly volatile
Net Receivables327.8 M368.7 M402 M
Slightly volatile
Good Will814.9 M916.8 M999.6 M
Slightly volatile
Inventory274.5 M308.8 M336.7 M
Slightly volatile

Conduit Pharmaceuticals Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization143.6 K151.1 K499.8 K
Very volatile
Selling General Administrative4.1 M5.9 M3.3 M
Slightly volatile
Other Operating Expenses2.3 B2.1 B277.8 M
Slightly volatile
Research Development118 M112.4 M14.6 M
Slightly volatile
Total Operating Expenses637.3 M607 M80.7 M
Slightly volatile
Gross Profit737.8 M830 M904.9 M
Slightly volatile
Cost Of Revenue1.2 B1.4 B1.5 B
Slightly volatile

Conduit Pharmaceuticals Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow626.9 M597 M76.7 M
Slightly volatile
End Period Cash Flow388.8 M370.3 M47.8 M
Slightly volatile
Change To Inventory19.5 M21.9 M23.9 M
Slightly volatile
Depreciation92.6 M104.2 M113.6 M
Slightly volatile
Dividends Paid6.6 M7.4 MM
Slightly volatile
Change To Account Receivables15.1 M17 M18.5 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.0880.10.111
Slightly volatile
Dividend Yield0.02350.02640.0288
Slightly volatile
Days Sales Outstanding48.6254.6959.6274
Slightly volatile
Stock Based Compensation To Revenue0.0090.01010.011
Slightly volatile
Capex To Depreciation0.840.951.0329
Slightly volatile
EV To Sales0.370.420.4543
Slightly volatile
Inventory Turnover3.584.044.4005
Slightly volatile
Days Of Inventory On Hand65.173.2579.8584
Slightly volatile
Payables Turnover3.94.394.7826
Slightly volatile
Research And Ddevelopement To Revenue0.03660.04110.0448
Slightly volatile
Capex To Revenue0.03960.04460.0486
Slightly volatile
Cash Per Share9.559.09971.1802
Slightly volatile
Payout Ratio0.0330.03720.0405
Slightly volatile
Capex To Operating Cash Flow0.280.320.3467
Slightly volatile
Days Payables Outstanding59.9167.473.4866
Slightly volatile
Income Quality3.451.73781.6968
Slightly volatile
ROE0.150.15330.584
Pretty Stable
Intangibles To Total Assets0.350.40.4322
Slightly volatile
Current Ratio1.061.9210.4304
Slightly volatile
Receivables Turnover4.815.415.8945
Slightly volatile
Graham Number47.2653.1757.974
Slightly volatile
Capex Per Share2.392.692.9369
Slightly volatile
Revenue Per Share48.3854.4359.3415
Slightly volatile
Interest Debt Per Share30.7529.2883.8341
Slightly volatile
Debt To Assets0.360.37682.6989
Slightly volatile
Operating Cycle114128139
Slightly volatile
Days Of Payables Outstanding59.9167.473.4866
Slightly volatile
Dividend Payout Ratio0.0330.03720.0405
Slightly volatile
Pretax Profit Margin0.07410.08340.0909
Slightly volatile
Ebt Per Ebit1.00.85541.083
Slightly volatile
Operating Profit Margin0.0880.09740.1063
Slightly volatile
Ebit Per Revenue0.0880.09740.1063
Slightly volatile
Quick Ratio0.951.370.389
Slightly volatile
Dividend Paid And Capex Coverage Ratio2.122.392.6023
Slightly volatile
Net Income Per E B T0.70.780.8542
Slightly volatile
Cash Ratio0.610.59470.2437
Slightly volatile
Cash Conversion Cycle53.8160.5365.9985
Slightly volatile
Operating Cash Flow Sales Ratio0.110.130.1376
Slightly volatile
Days Of Inventory Outstanding65.173.2579.8584
Slightly volatile
Days Of Sales Outstanding48.6254.6959.6274
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.520.580.6346
Slightly volatile
Fixed Asset Turnover3.213.613.9323
Slightly volatile
Capital Expenditure Coverage Ratio2.262.552.7772
Slightly volatile
Debt Ratio0.360.37682.6989
Slightly volatile
Price Sales Ratio0.0880.10.111
Slightly volatile
Asset Turnover0.60.680.7396
Slightly volatile
Net Profit Margin0.06450.07260.0791
Slightly volatile
Gross Profit Margin0.30.340.3679
Slightly volatile
Return On Equity0.150.15330.584
Pretty Stable

Conduit Fundamental Market Drivers

Cash And Short Term Investments370.3 M

About Conduit Pharmaceuticals Financial Statements

Conduit Pharmaceuticals investors use historical fundamental indicators, such as Conduit Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Conduit Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue2.5 B2.6 B
Cost Of Revenue1.4 B1.2 B
Stock Based Compensation To Revenue 0.01  0.01 
Research And Ddevelopement To Revenue 0.04  0.04 
Capex To Revenue 0.04  0.04 
Revenue Per Share 54.43  48.38 
Ebit Per Revenue 0.10  0.09 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Conduit Stock Analysis

When running Conduit Pharmaceuticals' price analysis, check to measure Conduit Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Conduit Pharmaceuticals is operating at the current time. Most of Conduit Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Conduit Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Conduit Pharmaceuticals' price. Additionally, you may evaluate how the addition of Conduit Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.